IL13 and chronic asthma: We demonstrate that vaccination against IL-4 and IL-13 is well tolerated and protects against key features of chronic asthma in mice, including AHR, eosinophilia, and mucus overproduction, after both prophylactic or therapeutic vaccination protocols.